quantisnow
FeedTopReportsPricing
⌘K
Live feed
08:22:52·672d
NEWSRelease
ASLAN Pharmaceuticals Limited logo
Actelis Networks Inc. logo
Bilibili Inc. logo
+17

Why Vuzix Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket

ASLN· ASLAN Pharmaceuticals LimitedASNS· Actelis Networks Inc.BILI· Bilibili Inc.DXF· Eason Technology LimitedGRDI· GRIID Infrastructure Inc.HUIZ· Huize Holding Limited
Health CareTelecommunicationsTechnology
Original source

Companies

  • ASLN
    ASLAN Pharmaceuticals Limited
    Health Care
  • ASNS
    Actelis Networks Inc.
    Telecommunications
  • BILI
    Bilibili Inc.
    Technology
  • DXF
    Eason Technology Limited
    Finance
  • GRDI
    GRIID Infrastructure Inc.
    Technology
  • HUIZ
    Huize Holding Limited
    Finance
  • KAVL
    Kaival Brands Innovations Group Inc.
    Consumer Discretionary
  • LRHC
    La Rosa Holdings Corp.
    Finance
  • MOLN
    Molecular Partners AG
    Health Care
  • NLSP
    NLS Pharmaceutics Ltd.
    Health Care
  • NXL
    Nexalin Technology Inc.
    Health Care
  • PRST
    Presto Automation Inc.
    Technology
  • SLNA
    Selina Hospitality PLC
    Consumer Discretionary
  • SLRX
    Salarius Pharmaceuticals Inc.
    Health Care
  • SMX
    SMX (Security Matters) Public Limited Company
    Technology
  • SVMH
    SRIVARU Holding Limited
    Consumer Discretionary
  • TPST
    Tempest Therapeutics Inc.
    Health Care
  • VIRI
    Virios Therapeutics Inc.
    Health Care
  • VNDA
    Vanda Pharmaceuticals Inc.
    Health Care
  • VUZI
    Vuzix Corporation
    Technology

Recent analyst ratings

  • Apr 13BILIUpdateMorgan Stanley$31.00
  • Mar 27BILIUpdateCitigroup$27.00
  • Mar 17BILIUpdateAnalyst$35.00
  • Mar 5VNDAUpdateTruist$18.00
  • Jan 27MOLNUpdateH.C. Wainwright$13.00
  • Jan 22TPSTUpdateH.C. Wainwright$11.00

Related

  • SEC10h
    SEC Form DEFA14A filed by Vanda Pharmaceuticals Inc.
  • SEC10h
    SEC Form DEF 14A filed by Vanda Pharmaceuticals Inc.
  • PR17h
    Actelis Networks Secures New Order for Alaska State Department of Transportation Intelligent Transportation System Project
  • SEC1d
    Vanda Pharmaceuticals Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
  • PR1d
    Vanda Pharmaceuticals Appoints Dr. Charles Duncan to its Board of Directors
  • SEC1d
    Nexalin Technology Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits
  • SEC1d
    La Rosa Holdings Corp. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Other Events, Financial Statements and Exhibits
  • PR1d
    Tempest Announces Key Manufacturing Milestone for TPST-2003 Dual-Targeting CD19/BCMA CAR-T
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022